To test this hypothesis, we investigated the expression of DKK1 and beta-catenin in tumor specimens from 85 patients with breast cancer and the correlation between DKK1 and beta-catenin together with other clinical pathological features of prognosis in this study. Here, DKK1 is linked to breast carcinoma.